Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists

Safety and Efficacy of Intravenous Zoledronic Acid in Paediatric Osteoporosis

(2011) J.J. Brown et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Bone Mineral Density and Fracture Rate in Response to Intravenous and Oral Bisphosphonates in Adult Osteogenesis Imperfecta

(2010) Jay R. Shapiro et al.   CALCIFIED TISSUE INTERNATIONAL

Alendronate for the Treatment of Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study

(2010) L. M. Ward et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efectos del tratamiento con ácido zoledrónico en pacientes adultos con osteogénesis imperfecta

(2010) Isabel Pavón de Paz et al.   Endocrinologia y Nutricion

A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta

(2009) Nick Bishop et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Risedronate in the Treatment of Mild Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study

(2009) Frank Rauch et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta

(2009) Hsiang-Yu Lin et al.   Pediatrics and Neonatology

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

(2008) R. G. G. Russell et al.   OSTEOPOROSIS INTERNATIONAL